ZA200609821B - Antifungal drug delivery - Google Patents

Antifungal drug delivery

Info

Publication number
ZA200609821B
ZA200609821B ZA200609821A ZA200609821A ZA200609821B ZA 200609821 B ZA200609821 B ZA 200609821B ZA 200609821 A ZA200609821 A ZA 200609821A ZA 200609821 A ZA200609821 A ZA 200609821A ZA 200609821 B ZA200609821 B ZA 200609821B
Authority
ZA
South Africa
Prior art keywords
drug delivery
antifungal drug
antifungal
delivery
drug
Prior art date
Application number
ZA200609821A
Other languages
English (en)
Inventor
Nimni Marcel
Pandya Anant
Original Assignee
Nimni Marcel
Pandya Anant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nimni Marcel, Pandya Anant filed Critical Nimni Marcel
Publication of ZA200609821B publication Critical patent/ZA200609821B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200609821A 2004-04-27 2005-04-25 Antifungal drug delivery ZA200609821B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/832,933 US20050238672A1 (en) 2004-04-27 2004-04-27 Antifungal drug delivery

Publications (1)

Publication Number Publication Date
ZA200609821B true ZA200609821B (en) 2008-06-25

Family

ID=35136720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200609821A ZA200609821B (en) 2004-04-27 2005-04-25 Antifungal drug delivery

Country Status (14)

Country Link
US (1) US20050238672A1 (ru)
EP (1) EP1755575A4 (ru)
JP (1) JP2007534764A (ru)
KR (1) KR20070024543A (ru)
CN (1) CN101022779B (ru)
AU (1) AU2005237541A1 (ru)
BR (1) BRPI0510286A (ru)
CA (1) CA2564134A1 (ru)
IL (1) IL178750A0 (ru)
MX (1) MXPA06012426A (ru)
NO (1) NO20065422L (ru)
RU (1) RU2006141653A (ru)
WO (1) WO2005105072A2 (ru)
ZA (1) ZA200609821B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
MXPA05012961A (es) * 2005-11-30 2007-05-30 Fernando Ahumada Ayala Preparaciones para el cuidado de las unas que contienen clorhidrato de terbinafina.
WO2007098591A2 (en) * 2006-03-02 2007-09-07 Nuvo Research Inc. Topical nail formulation
JP2010519288A (ja) * 2007-02-21 2010-06-03 パワー ペイパー リミテッド イオン導入法のためのテルビナフィン製剤
GB201011212D0 (en) * 2010-07-02 2010-08-18 Linde Aktiengesellshcaft Gas storage apparatus
KR20120056314A (ko) * 2010-11-24 2012-06-04 주식회사유한양행 테르비나핀 또는 그의 염을 함유하는 국소 항진균 조성물
WO2014059008A1 (en) 2012-10-09 2014-04-17 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
CN104703585A (zh) 2012-10-09 2015-06-10 宝洁公司 鉴定协同化妆品组合的方法
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
EP2952208A1 (en) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Hydroalcoholic system for nail treatment
US11554108B2 (en) 2016-08-29 2023-01-17 Xeropedix, Inc. Methods and compositions for treating cutaneous fungal infections
EP3503874A1 (en) * 2016-08-29 2019-07-03 Carl F. Schanbacher Methods and compositions for treating cutaneous fungal infections
RU2699653C1 (ru) * 2019-03-22 2019-09-09 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се Средство для лечения микоза ногтей
WO2021072027A1 (en) * 2019-10-08 2021-04-15 Hallux Inc. Onychomycosis treatment compositions and methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3382151A (en) * 1964-01-13 1968-05-07 Mavala Sa Composition for strengthening nails
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4820724A (en) * 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5487776A (en) * 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5652256A (en) * 1995-06-06 1997-07-29 Knowles; W. Roy Topical composition for fungal treatment
US5814308A (en) * 1996-03-26 1998-09-29 Zhang; Ke Methods for the treatment of gastrointestinal tract disorders
US6030948A (en) * 1997-12-19 2000-02-29 Mann; Morris A. Hair regeneration compositions for treatment of alopecia and methods of application related thereto
PT983037E (pt) * 1998-02-09 2003-09-30 Macrochem Corp Verniz para unhas antifungico
EP1071413B1 (en) * 1998-04-17 2004-06-16 Bertek Pharmaceuticals, Inc. Topical formulations for the treatment of nail fungal diseases
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
JP4540667B2 (ja) * 2003-03-21 2010-09-08 ネクスメツド・ホールデイングス・インコーポレイテツド 抗真菌性ネイルコート
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények

Also Published As

Publication number Publication date
WO2005105072A2 (en) 2005-11-10
IL178750A0 (en) 2007-05-15
US20050238672A1 (en) 2005-10-27
WO2005105072A3 (en) 2006-03-02
BRPI0510286A (pt) 2007-10-30
EP1755575A2 (en) 2007-02-28
AU2005237541A1 (en) 2005-11-10
NO20065422L (no) 2007-01-19
MXPA06012426A (es) 2007-03-28
RU2006141653A (ru) 2008-06-10
JP2007534764A (ja) 2007-11-29
KR20070024543A (ko) 2007-03-02
EP1755575A4 (en) 2010-09-22
CN101022779B (zh) 2010-12-08
CN101022779A (zh) 2007-08-22
CA2564134A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
IL178750A0 (en) Antifungal drug delivery
HK1252167A1 (zh) 用於藥物輸送的脂質體
PL3437682T3 (pl) Urządzenie do podawania leków
EP1802258A4 (en) BIOSYNCHRONE TRANSDERMAL MEDICINES
EP1781355A4 (en) DEVICE FOR DELIVERY OF DRUGS
IL169807A (en) Device for administering a drug
EG24701A (en) Cap for drug delivery devices
ZA200700851B (en) Medicament dispenser
SG114683A1 (en) Medicament dispenser
EP1765158A4 (en) DISPENSER
IL205496A0 (en) Medication delivery device
GB0402736D0 (en) A drug delivery device
EP1795182A4 (en) LIPOSOME IMPROVING INTRACELLULAR DRUG DELIVERY
GB0414224D0 (en) Delivery device
GB0401008D0 (en) Drug delivery system
GB0403558D0 (en) Drug delivery
GB0409506D0 (en) Drug delivery
GB0402698D0 (en) Delivery device
GB0413234D0 (en) Drug delivery compounds
GB0508579D0 (en) Drug delivery
GB0400749D0 (en) Dose delivery
GB0400586D0 (en) Nasal drug delivery
GB2410485B (en) Medicament delivery system
GB0411286D0 (en) Liquid delivery
GB0311084D0 (en) Drug delivery